| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Phibro Animal Health Corporation
13D/A
Amendment 25
PAHC · 71742Q106
|
48.2% |
5/22/2026
Event 5/20/2026
|
|||
| BFI Co., LLC | 48.2% | ||||
| Jack C. Bendheim | 48.2% | ||||
|
Phibro Animal Health Corporation
13D/A
Amendment 24
PAHC · 71742Q106
|
48.3% |
4/23/2026
Event 4/21/2026
|
|||
| BFI Co., LLC | 48.3% | ||||
| Jack C. Bendheim | 48.3% | ||||
|
Phibro Animal Health Corporation
13D/A
Amendment 23
PAHC · 71742Q106
|
49.3% |
12/15/2025
Event 12/11/2025
|
|||
| BFI Co., LLC | 49.3% | ||||
| Jack C. Bendheim | 49.3% | ||||
|
Phibro Animal Health Corporation
13D/A
Amendment 22
PAHC · 71742Q106
|
49.9% |
6/3/2025
Event 5/30/2025
|
|||
| BFI Co., LLC | 49.9% | ||||
| Jack C. Bendheim | 49.9% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.